Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Zimmer Biomet Holdings Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Zimmer Biomet Holdings Inc. May 22, 202697.5%
-
ResMed Inc. November 19, 202594.9%
-
Zimmer Biomet Holdings Inc. May 29, 202598.9%
-
ResMed Inc. November 20, 202495.7%
-
Zimmer Biomet Holdings Inc. May 10, 202497.3%
-
ResMed Inc. November 16, 202392.5%
-
Zimmer Biomet Holdings Inc. May 12, 202398.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Oct 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $226.33 | $1,129,637 |
| Sep 8, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Sep 8, 2026 | ResMed Inc. | Open-market sale | −4,991 | $222.44 | $1,110,198 |
| Aug 14, 2026 | ResMed Inc. | Grant or award | +13,547 | — | — |
| Aug 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Aug 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $205.69 | $1,026,599 |
| Jul 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Jul 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $218.55 | $1,090,783 |
| Jun 8, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Jun 8, 2026 | ResMed Inc. | Open-market sale | −4,991 | $193.96 | $968,054 |
| May 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| May 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $207.82 | $1,037,230 |
| Apr 7, 2026 | ResMed Inc. | Option exercise | +4,991 | $146.34 | $730,383 |
| Apr 7, 2026 | ResMed Inc. | Open-market sale | −4,991 | $225.50 | $1,125,471 |
Questions about Michael J. Farrell
What boards is Michael J. Farrell on?
Michael J. Farrell sits on the boards of ResMed Inc. and Zimmer Biomet Holdings Inc.
What company is Michael J. Farrell the CEO of?
Michael J. Farrell is Chairman and CEO of ResMed Inc.
How long has Michael J. Farrell served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.